Developer docs
API playgroundTry for free, no card

Search company profiles

SpineGuard

Full company profile

uuid0003xqa

Namestring
SpineGuard
Legal namestring
SpineGuard
Websiteurl
spineguard.com
Company typeenum
Public
Founded yearint
2009
Descriptiontext

SpineGuard is a French publicly-traded medical device company (Euronext Growth Paris: ALSGD), founded in 2009 and headquartered in Vincennes near Paris. It designs, manufactures, and supplies a portfolio of single-use handheld surgical drilling instruments under the PediGuard brand, differentiated by its proprietary DSG (Dynamic Surgical Guidance) technology. DSG uses a bipolar sensor at the instrument tip to measure electrical conductivity of tissues at 5 Hz and emits real-time audio cues that allow spine surgeons to distinguish cancellous bone, cortical bone, and soft tissue, anticipating pedicle wall breaches during screw placement. The product line spans Straight, Curved, Cannulated, Threaded, and XS variants, complemented by the DSG Connect tablet application platform and an extension into sacroiliac joint fusion via the PsiFGuard device developed in partnership with Omnia Medical.

The company serves spine surgeons and hospitals performing spinal fusion, deformity correction, scoliosis treatment, minimally invasive procedures, and sacroiliac fusion. It generates revenue primarily through hardware sales of sterile single-use devices to hospitals and spine surgery centers, with pricing determined by institutional procurement rather than public list rates. Following the April 2026 transfer of its US subsidiary, SpineGuard commercializes in the US exclusively through Omnia Medical while retaining direct sales in Europe and distribution partnerships with XinRong Medical in China and WishBone Medical in US pediatric markets. The platform is FDA-cleared, CE-marked, EC-MDR certified, NMPA-approved in China, and registered in more than 30 countries, supported by 39 peer-reviewed publications and over 110,000 surgeries performed using DSG technology.

Operationally, SpineGuard is a sub-scale specialist with 11-50 employees and FY2025 revenue of €3,757K, currently operating at a loss while pursuing operational breakeven by end of 2026. The company is also extending DSG into surgical robotics (via Sorbonne University, CNRS/Inserm, and the FAROS Horizon 2020 consortium) and into dental implantology, building a long-term platform thesis around real-time bone-tissue sensing across multiple implant procedures.

Short descriptiontext

SpineGuard designs and supplies PediGuard handheld surgical instruments with proprietary DSG electrical-conductivity sensing technology, providing spine surgeons real-time audio feedback to avoid pedicle breaches during screw placement, sold to hospitals across 30+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVincennes, France
HQ citystring
Vincennes
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spine surgery devices, pedicle screw guidance, surgical navigation systems, real-time bone sensing, minimally invasive spine
Industry3 codes
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Spine Surgery Medical Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1PediGuard Device Sales
TypeHardware Sales
Description

SpineGuard generates revenue primarily through the sale of its PediGuard devices with DSG technology. These are single-use, sterile surgical instruments sold to hospitals and spine surgery centers globally. Revenue is recognized upon product delivery.

morningstar.com
2Distribution and Licensing Revenue
TypeLicensing Royalties
Description

Following the US asset transfer to Omnia Medical, SpineGuard supplies PediGuard devices to Omnia Medical as the exclusive US distributor, generating recurring revenue through product supply agreements. The company also receives licensing considerations from various partnership arrangements.

businesswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1PediGuard product line pricing (specific tiers not disclosed)
ModelOtherBilling cadencePay-as-you-go
Notes

Single-use sterile surgical instruments; pricing determined through hospital procurement and institutional quotation processes. No public pricing available.

spineguard.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1PediGuard
Description

Handheld drilling devices with DSG technology for secure pedicle screw placement in spine surgery

spineguard.com
+3 more records
Core offering1 text field

SpineGuard designs, manufactures, and commercializes the PediGuard family of single-use, sterile surgical drilling instruments equipped with proprietary DSG (Dynamic Surgical Guidance) technology. DSG measures tissue electrical conductivity in real time to detect potential vertebral cortical breaches during pedicle screw placement, providing audio feedback to surgeons without requiring X-ray imaging. The portfolio extends to the DSG Connect digital tablet platform, PsiFGuard for sacroiliac joint fusion, and DSG integrations for orthopedic robotics and dental implantology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 97% screw placement accuracy including in osteoporotic patients
+8 more records
Product overview1 text field

SpineGuard has developed a platform-based product portfolio centered on its proprietary DSG (Dynamic Surgical Guidance) technology, which provides real-time electrical conductivity-based tissue sensing for skeletal implant placement. The core product line consists of the PediGuard family of drilling instruments available in multiple variants: Straight, Curved, Cannulated, Threaded, and XS models. These handheld devices alert surgeons in real-time to potential vertebral cortical breaches during pedicle screw placement. The DSG Connect platform adds a digital tablet interface for enhanced monitoring. Recent expansion includes PsiFGuard for sacroiliac joint fusion and applications for orthopedic robotics and dental implantology. The company also developed an ultrasound technology for robot-assisted surgery in collaboration with Sorbonne University.

Product and service1 record
1PediGuard Straight
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-13
Description

SpineGuard completed the transfer of SpineGuard Inc. assets and entered an exclusive US distribution agreement for PediGuard devices. Omnia Medical assumed full commercialization responsibility, integrating the technology into its spine implant portfolio focused on minimally invasive and outpatient procedures. SpineGuard continues designing and manufacturing while supplying products to Omnia Medical. The transaction is expected to reduce SpineGuard's structural costs and supports its objective of achieving operational breakeven by end of 2026.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-20
Description

Partnership for development of PsiF Guard technology integrated into Omnia Medical's PsiF DNA Sacroiliac Joint Stabilization System. The technology provides real-time intraoperative guidance for sacroiliac joint fusion procedures. FDA-cleared in May 2025 with commercial launch in January 2026.

3Sorbonne University
Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2025-12-17
Description

Collaboration with Sorbonne University for development of new ultrasound robot-assisted technology for spine surgery. The technology allows determination of entry points and trajectories without X-rays. PhD thesis by Andrés Pérez Velásquez presented positive results validating the technology.

pharmiweb.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-05-16
Description

Expanded collaboration in China to include distribution, registration funding, and potential co-development of DSG technology-based spinal surgery devices. In July 2023, XinRong placed a large purchase order of 448 PediGuard units and invested €500,000 through capital increase to fund regulatory approval in China. The partnership leverages SpineGuard's DSG technology in China, the world's second-largest spinal market, with focus on market access and new device development. Three new PediGuard models (Curved and XS) received NMPA clearance in December 2025.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-12
Description

Strategic alliance announced for adult spine surgery in the United States, marking the beginning of the partnership that evolved into the April 2026 asset transfer and exclusive distribution agreement.

6CNRS and Inserm
Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2022-06-07
Description

New partnership with Sorbonne, CNRS and Inserm to associate DSG technology with ultrasound and serve surgical robots, expanding the technology platform for robotic applications.

spineguard.com
Strategic tierSecondaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-01-06
Description

National distribution agreement for US pediatric orthopedic centers. New partnership to broaden access for pediatric orthopedic surgeons performing spine surgery.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-07-19
Description

SpineGuard joined the Horizon 2020 project FAROS (Functional Accurate RObotic Surgery) as consortium member. The European project focuses on robotic surgery development.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-07-12
Description

Expansion of strategic partnership with ConfiDent, building on existing collaboration relationship.

10ISIR (Institut des Systèmes Intelligents et de la Robotique)
Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Collaboration started in 2017 for application of DSG technology to surgical robots and enhancement of their safety, accuracy, and autonomy.

spineguard.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Orthopedic device company with ROSA Spine robotic system and broader spine implant portfolio. Comparable as a large incumbent offering computer-assisted spine surgery that competes with SpineGuard's handheld DSG concept.

TypeBroad incumbent
Description

Diversified medical device company with spine navigation offerings (SpineMap, Q Guidance System) and orthopedic robotics. Comparable to SpineGuard as an incumbent offering computer-assisted spine surgery in hospital settings, with far greater scale and resources.

TypeBroad incumbent
Description

Spine surgery specialist (now part of Globus Medical) known for less-invasive and intraoperative neuromonitoring solutions. Comparable as a focused spine incumbent whose products and approach to surgical precision and safety parallel SpineGuard's positioning.

TypeEmerging player
Description

Emerging surgical navigation company offering xvision augmented-reality guidance for spine surgery. Comparable as a smaller, focused competitor developing next-generation spine navigation, though differentiated by its AR-based approach versus SpineGuard's conductivity sensing.

TypeBroad incumbent
Description

Established surgical navigation and planning software company with strong presence in spine and neurosurgery. Competes in the same intraoperative guidance category as SpineGuard but with a much broader software-and-hardware platform and global installed base.

TypeBroad incumbent
Description

Global leader in spinal surgery with StealthStation surgical navigation and Mazor robotic spine systems. While much larger and broader than SpineGuard, Medtronic defines the competitive landscape in spine surgical guidance and robotics, and its integrated platforms compete with SpineGuard's standalone handheld DSG approach.

TypeBroad incumbent
Description

Major spine device company offering ExcelsiusGPS robotic navigation platform. Following its merger with NuVasive, Globus Medical is one of the largest spine competitors and represents the integrated navigation-plus-implants model that SpineGuard must compete against.

TypeEmerging player
Description

Emerging surgical guidance company using light field technology and computer vision for spine and orthopedic procedures. Comparable as a smaller, technology-forward navigation company competing for the same surgeon mindshare in intraoperative spine guidance.

TypeDirect peer
Description

Spine surgical navigation company using machine-vision technology for radiation-free screw placement. Most directly comparable to SpineGuard as a focused, smaller company offering intraoperative guidance for pedicle screw placement with similar value proposition around reducing radiation exposure.

TypeBroad incumbent
Description

Spine and orthopedic device company offering spine hardware, biologics, and enabling technologies. Comparable as a mid-sized spine incumbent whose product portfolio overlaps SpineGuard's end customers (spine surgeons and hospitals).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SpineGuard

Spine Surgery Medical Devicesspineguard.com

SpineGuard designs and supplies PediGuard handheld surgical instruments with proprietary DSG electrical-conductivity sensing technology, providing spine surgeons real-time audio feedback to avoid pedicle breaches during screw placement, sold to hospitals across 30+ countries.

What SpineGuard does

SpineGuard is a French publicly-traded medical device company (Euronext Growth Paris: ALSGD), founded in 2009 and headquartered in Vincennes near Paris. It designs, manufactures, and supplies a portfolio of single-use handheld surgical drilling instruments under the PediGuard brand, differentiated by its proprietary DSG (Dynamic Surgical Guidance) technology. DSG uses a bipolar sensor at the instrument tip to measure electrical conductivity of tissues at 5 Hz and emits real-time audio cues that allow spine surgeons to distinguish cancellous bone, cortical bone, and soft tissue, anticipating pedicle wall breaches during screw placement. The product line spans Straight, Curved, Cannulated, Threaded, and XS variants, complemented by the DSG Connect tablet application platform and an extension into sacroiliac joint fusion via the PsiFGuard device developed in partnership with Omnia Medical.

The company serves spine surgeons and hospitals performing spinal fusion, deformity correction, scoliosis treatment, minimally invasive procedures, and sacroiliac fusion. It generates revenue primarily through hardware sales of sterile single-use devices to hospitals and spine surgery centers, with pricing determined by institutional procurement rather than public list rates. Following the April 2026 transfer of its US subsidiary, SpineGuard commercializes in the US exclusively through Omnia Medical while retaining direct sales in Europe and distribution partnerships with XinRong Medical in China and WishBone Medical in US pediatric markets. The platform is FDA-cleared, CE-marked, EC-MDR certified, NMPA-approved in China, and registered in more than 30 countries, supported by 39 peer-reviewed publications and over 110,000 surgeries performed using DSG technology.

Operationally, SpineGuard is a sub-scale specialist with 11-50 employees and FY2025 revenue of €3,757K, currently operating at a loss while pursuing operational breakeven by end of 2026. The company is also extending DSG into surgical robotics (via Sorbonne University, CNRS/Inserm, and the FAROS Horizon 2020 consortium) and into dental implantology, building a long-term platform thesis around real-time bone-tissue sensing across multiple implant procedures.

SpineGuard firmographics

Firmographics
Name
SpineGuard
Legal name
SpineGuard
Website
https://spineguard.com
Company type
Public
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
SpineGuard designs and supplies PediGuard handheld surgical instruments with proprietary DSG electrical-conductivity sensing technology, providing spine surgeons real-time audio feedback to avoid pedicle breaches during screw placement, sold to hospitals across 30+ countries.
Ownership category
akta.pro rank

SpineGuard industry classification

Industry
Product category
Spine Surgery Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Spine surgery devices
  • Pedicle screw guidance
  • Surgical navigation systems
  • Real-time bone sensing
  • Minimally invasive spine

Where SpineGuard is headquartered

Location

Headquarters

HQ city
Vincennes
HQ country
France
HQ region
Europe

Offices2 records

Markets served

SpineGuard business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. PediGuard Device Sales: SpineGuard generates revenue primarily through the sale of its PediGuard devices with DSG technology. These are single-use, sterile surgical instruments sold to hospitals and spine surgery centers globally. Revenue is recognized upon product delivery.
  2. Distribution and Licensing Revenue: Following the US asset transfer to Omnia Medical, SpineGuard supplies PediGuard devices to Omnia Medical as the exclusive US distributor, generating recurring revenue through product supply agreements. The company also receives licensing considerations from various partnership arrangements.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPediGuard product line pricing (specific tiers not disclosed)

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

SpineGuard product offering

Product offering

Core offering

SpineGuard designs, manufactures, and commercializes the PediGuard family of single-use, sterile surgical drilling instruments equipped with proprietary DSG (Dynamic Surgical Guidance) technology. DSG measures tissue electrical conductivity in real time to detect potential vertebral cortical breaches during pedicle screw placement, providing audio feedback to surgeons without requiring X-ray imaging. The portfolio extends to the DSG Connect digital tablet platform, PsiFGuard for sacroiliac joint fusion, and DSG integrations for orthopedic robotics and dental implantology.

Product overview

SpineGuard has developed a platform-based product portfolio centered on its proprietary DSG (Dynamic Surgical Guidance) technology, which provides real-time electrical conductivity-based tissue sensing for skeletal implant placement. The core product line consists of the PediGuard family of drilling instruments available in multiple variants: Straight, Curved, Cannulated, Threaded, and XS models. These handheld devices alert surgeons in real-time to potential vertebral cortical breaches during pedicle screw placement. The DSG Connect platform adds a digital tablet interface for enhanced monitoring. Recent expansion includes PsiFGuard for sacroiliac joint fusion and applications for orthopedic robotics and dental implantology. The company also developed an ultrasound technology for robot-assisted surgery in collaboration with Sorbonne University.

Differentiator

Problem solved

Functional benefit

Brands

  • PediGuard: Handheld drilling devices with DSG technology for secure pedicle screw placement in spine surgery
  • DSG Connect
  • DSG (Dynamic Surgical Guidance)
  • PsiFGuard

Products and services

  • PediGuard Straight

Quantifiable outcome

  • 97% screw placement accuracy including in osteoporotic patients
  • +8 more outcomes

Companies that use SpineGuard

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

SpineGuard technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

SpineGuard partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, secondary and minor.

  • Omnia MedicalcoreChannel Partner/ Reseller/ Distributor · 13 April 2026SpineGuard completed the transfer of SpineGuard Inc. assets and entered an exclusive US distribution agreement for PediGuard devices. Omnia Medical assumed full commercialization responsibility, integrating the technology into its spine implant portfolio focused on minimally invasive and outpatient procedures. SpineGuard continues designing and manufacturing while supplying products to Omnia Medical. The transaction is expected to reduce SpineGuard's structural costs and supports its objective of achieving operational breakeven by end of 2026.
  • Omnia Medical (PsiF Guard Technology)coreTechnology or Integration · 20 January 2026Partnership for development of PsiF Guard technology integrated into Omnia Medical's PsiF DNA Sacroiliac Joint Stabilization System. The technology provides real-time intraoperative guidance for sacroiliac joint fusion procedures. FDA-cleared in May 2025 with commercial launch in January 2026.
  • Sorbonne UniversitysecondaryStrategic or Co-development Partner · 17 December 2025Collaboration with Sorbonne University for development of new ultrasound robot-assisted technology for spine surgery. The technology allows determination of entry points and trajectories without X-rays. PhD thesis by Andrés Pérez Velásquez presented positive results validating the technology.
  • XinRong Medical GroupcoreChannel Partner/ Reseller/ Distributor · 16 May 2023Expanded collaboration in China to include distribution, registration funding, and potential co-development of DSG technology-based spinal surgery devices. In July 2023, XinRong placed a large purchase order of 448 PediGuard units and invested €500,000 through capital increase to fund regulatory approval in China. The partnership leverages SpineGuard's DSG technology in China, the world's second-largest spinal market, with focus on market access and new device development. Three new PediGuard models (Curved and XS) received NMPA clearance in December 2025.
  • Omnia Medical (Strategic Alliance)coreStrategic or Co-development Partner · 12 September 2022Strategic alliance announced for adult spine surgery in the United States, marking the beginning of the partnership that evolved into the April 2026 asset transfer and exclusive distribution agreement.
  • CNRS and InsermsecondaryStrategic or Co-development Partner · 7 June 2022New partnership with Sorbonne, CNRS and Inserm to associate DSG technology with ultrasound and serve surgical robots, expanding the technology platform for robotic applications.
  • WishBone MedicalsecondaryChannel Partner/ Reseller/ Distributor · 6 January 2022National distribution agreement for US pediatric orthopedic centers. New partnership to broaden access for pediatric orthopedic surgeons performing spine surgery.
  • FAROS Consortium (Horizon 2020)minorStrategic or Co-development Partner · 19 July 2021SpineGuard joined the Horizon 2020 project FAROS (Functional Accurate RObotic Surgery) as consortium member. The European project focuses on robotic surgery development.
  • ConfiDentminorStrategic or Co-development Partner · 12 July 2021Expansion of strategic partnership with ConfiDent, building on existing collaboration relationship.
  • ISIR (Institut des Systèmes Intelligents et de la Robotique)secondaryStrategic or Co-development Partner · 1 January 2017Collaboration started in 2017 for application of DSG technology to surgical robots and enhancement of their safety, accuracy, and autonomy.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

SpineGuard competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet: Orthopedic device company with ROSA Spine robotic system and broader spine implant portfolio. Comparable as a large incumbent offering computer-assisted spine surgery that competes with SpineGuard's handheld DSG concept.
  • Stryker: Diversified medical device company with spine navigation offerings (SpineMap, Q Guidance System) and orthopedic robotics. Comparable to SpineGuard as an incumbent offering computer-assisted spine surgery in hospital settings, with far greater scale and resources.
  • NuVasive: Spine surgery specialist (now part of Globus Medical) known for less-invasive and intraoperative neuromonitoring solutions. Comparable as a focused spine incumbent whose products and approach to surgical precision and safety parallel SpineGuard's positioning.
  • Brainlab: Established surgical navigation and planning software company with strong presence in spine and neurosurgery. Competes in the same intraoperative guidance category as SpineGuard but with a much broader software-and-hardware platform and global installed base.
  • Medtronic: Global leader in spinal surgery with StealthStation surgical navigation and Mazor robotic spine systems. While much larger and broader than SpineGuard, Medtronic defines the competitive landscape in spine surgical guidance and robotics, and its integrated platforms compete with SpineGuard's standalone handheld DSG approach.
  • Globus Medical: Major spine device company offering ExcelsiusGPS robotic navigation platform. Following its merger with NuVasive, Globus Medical is one of the largest spine competitors and represents the integrated navigation-plus-implants model that SpineGuard must compete against.
  • Orthofix: Spine and orthopedic device company offering spine hardware, biologics, and enabling technologies. Comparable as a mid-sized spine incumbent whose product portfolio overlaps SpineGuard's end customers (spine surgeons and hospitals).

Emerging players

  • Augmedics: Emerging surgical navigation company offering xvision augmented-reality guidance for spine surgery. Comparable as a smaller, focused competitor developing next-generation spine navigation, though differentiated by its AR-based approach versus SpineGuard's conductivity sensing.
  • Proprio Vision: Emerging surgical guidance company using light field technology and computer vision for spine and orthopedic procedures. Comparable as a smaller, technology-forward navigation company competing for the same surgeon mindshare in intraoperative spine guidance.

Direct peers

  • 7D Surgical: Spine surgical navigation company using machine-vision technology for radiation-free screw placement. Most directly comparable to SpineGuard as a focused, smaller company offering intraoperative guidance for pedicle screw placement with similar value proposition around reducing radiation exposure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SpineGuard social profiles

Digital presence

SpineGuard compliance and trust

Trust signal

Compliance8 records

SpineGuard financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SpineGuard leadership team

Management profile

Number of profiles

Profiles12 records

SpineGuard subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

SpineGuard funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SpineGuard M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpineGuard

What does SpineGuard do?

SpineGuard designs, manufactures, and commercializes the PediGuard family of single-use, sterile surgical drilling instruments equipped with proprietary DSG (Dynamic Surgical Guidance) technology. DSG measures tissue electrical conductivity in real time to detect potential vertebral cortical breaches during pedicle screw placement, providing audio feedback to surgeons without requiring X-ray imaging. The portfolio extends to the DSG Connect digital tablet platform, PsiFGuard for sacroiliac joint fusion, and DSG integrations for orthopedic robotics and dental implantology.

Is SpineGuard a public or private company?

SpineGuard is a public company. It is classified as public and is currently operating.

When was SpineGuard founded?

SpineGuard was founded in 2009. It employs 11 to 50 people.

Where is SpineGuard based?

SpineGuard is headquartered in Vincennes, France, in the Europe region.

How does SpineGuard make money?

Two revenue lines are on record. PediGuard Device Sales are the primary driver. The others are distribution and Licensing Revenue.

Who are SpineGuard's main competitors?

Broad incumbents on record are Zimmer Biomet, Stryker, NuVasive, Brainlab, Medtronic, Globus Medical and Orthofix. Emerging players are Augmedics and Proprio Vision. 7D Surgical is listed as a direct peer.

Does SpineGuard have an API?

No public API is recorded for SpineGuard.

What industry is SpineGuard in?

SpineGuard's product category is Spine Surgery Medical Devices. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooSpineGuard Announces Its Q3 RevenueSpineGuard reported Q3 2026 revenue of €662K, down 14% at current exchange rates, while unit sales rose 22% to 1,398. The decline reflects a shift to a distribution model in the U.S. with Omnia Medical, and the company targets operating breakeven in Q4 2026.Business Wire BlogSpineGuard Announces Its Q3 RevenueSpineGuard reported Q3 2026 revenue of €662K, down 14% at current rates, while unit sales rose 22% to 1,398. The decline reflects a shift to a distribution model with Omnia Medical in the U.S., but international sales grew 25%. The company aims to reach operating breakeven in Q4 2026.Business Wire BlogSpineGuard Reports 2026 Half-Year ResultsSpineGuard reported first-half 2026 revenue of €1,449K, down 32% year-over-year, and a net loss of €1,226K. The decline stems from a shift to a distribution model in the U.S. and inventory build-up. The company expects operational breakeven in the fourth quarter of 2026.MarketScreenerSpineGuard lands a new US patent in spinal guidanceSpineGuard said the USPTO validated a new patent covering robot-assisted ultrasound technology that determines spinal entry points and pedicle trajectories from the bony surface without X-rays. The company describes the innovation as complementary to its DSG technology, which detects bone breaches in real time via tissue electrical conductivity, and is seeking an industrial partner to commercialize it. Its portfolio includes 11 patent families and three registered trademarks.Business Wire BlogSpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling TrajectorySpineGuard, a French medical device company, announced on August 24, 2026 that the USPTO granted it a new U.S. patent for robotically assisted ultrasound technology that determines the entry point and pedicle drilling trajectory from the posterior surface of the spine without X-rays. Deputy CEO Stéphane Bette said the technology complements SpineGuard's DSG real-time bone breach detection, and the company will seek an industrial partner to commercialize it.MarketScreenerSpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance TechnologySpineGuard and Omnia Medical have obtained a new US patent for dynamic surgical guidance technology, representing an expansion of their intellectual property portfolio in the medical device space.MorningstarSpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint FusionSpineGuard and Omnia Medical received USPTO notice of allowance for a joint patent on using DSG technology to guide sacroiliac joint fusion implant placement. The sterile surgical kit includes Omnia's implants and SpineGuard's PsiFGuard guidance tool, aiming to accelerate U.S. commercial deployment. The companies plan to accelerate the product launch in the U.S. as part of their 2025 roadmap.Business Wire BlogSpineGuard Announces its H1 2026 RevenueSpineGuard reported H1 2026 revenue of €1,448K, a 32% decline compared to €2,120K in H1 2025, driven by the strategic transition from direct sales to a distribution model in the United States following the sale of SpineGuard Inc. and partnership with Omnia Medical. US revenue fell 47% in dollar terms to $776K, while the rest of the world grew 17%, with Europe showing particularly strong performance. The company stated achieving operational breakeven by Q4 2026 remains its top priority, with cash position of €763K as of June 30, 2026.Business Wire BlogSpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®SpineGuard and Omnia Medical have completed the transfer of SpineGuard Inc. assets and finalized an exclusive U.S. distribution agreement for PediGuard® devices, with Omnia Medical assuming full commercialization responsibility for the products. Under the agreement, SpineGuard will continue designing and manufacturing PediGuard® devices while supplying them to Omnia Medical, which will integrate the technology into its broader spine implant portfolio focused on minimally invasive and outpatient procedures. The transaction is expected to reduce SpineGuard's structural costs and supports its objective of achieving operational breakeven by the end of 2026.